Skip to main content
WOOREE BIO CO., LTD logo

WOOREE BIO CO., LTD — Investor Relations & Filings

Ticker · 082850 ISIN · KR7082850009 KO Manufacturing
Open in API
Filings indexed 201 across all filing types
Latest filing 2025-03-20 Audit Report / Informat…
Country KR South Korea
Listing KO 082850

About WOOREE BIO CO., LTD

http://www.wooreebio.co.kr/en/

WOOREE BIO CO., LTD. is a diversified company with two primary business divisions: health functional foods and electronic components. As a specialized OEM/ODM manufacturer, the company produces a range of health functional foods, focusing on the research, development, and sourcing of natural and functional raw materials. It emphasizes open innovation to develop new, individually recognized ingredients. The electronics division manufactures and sells components for the display and lighting industries, including LED package modules and flexible printed circuit boards (FPCBs).

Recent filings

Filing Released Lang Actions
사업보고서 (2024.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for Woori Bio Co., Ltd. for the fiscal year ending December 31, 2024. It includes the independent auditor's report, financial statements (Statement of Financial Position, Comprehensive Income Statement, Statement of Changes in Equity, Cash Flow Statement), and detailed notes to the financial statements. While it contains financial data, it is specifically the audit report and accompanying financial statements, which falls under the 'Audit Report / Information' category. FY 2024
2025-03-20 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company '우리바이오'. It outlines the date, location, and specific agenda items for the upcoming Annual General Meeting (AGM), including the approval of financial statements, election of directors, and remuneration limits. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting and request their participation/votes. Therefore, it falls under the Proxy Solicitation & Information Statement category.
2025-03-13 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted by Woori Bio regarding the scheduling of their Annual General Meeting (AGM) on a 'concentrated date' (a date where many companies hold their AGMs). It explains the reasons for choosing this date despite regulatory efforts to avoid such concentration. Since this is a regulatory notification regarding meeting logistics rather than the AGM presentation materials themselves, and it does not fit into specific categories like proxy solicitation or voting results, it is classified as a general regulatory filing.
2025-03-13 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Wooree Bio Co., Ltd. It details the meeting date, location, agenda items (financial statement approval, director appointments, etc.), and provides management reference materials (business overview, board activities, and related party transactions). This document is a formal proxy statement and information package sent to shareholders to solicit votes for the upcoming Annual General Meeting. In the context of the provided categories, this fits the definition of a Proxy Solicitation & Information Statement.
2025-03-13 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy/Voting Rights). It contains information regarding the upcoming Annual General Meeting (AGM), including the purpose of the meeting, voting procedures (electronic/proxy), and summary financial statements. This document is a standard proxy solicitation statement provided to shareholders to request their votes for the AGM, which falls under the 'Proxy Solicitation & Information Statement' category.
2025-03-13 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Woori Bio) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement in the Korean market (KRX) for preliminary financial results before the final audit is completed. Since it provides key financial highlights (revenue, operating profit, net income) and explains the reasons for the variance, it fits the definition of an Earnings Release (ER). FY 2024
2025-02-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.